Balance between MKK6 and MKK3 Mediates p38 MAPK Associated Resistance to Cisplatin in NSCLC
Eva María Galán‐Moya(Hospital General Universitario de Albacete), Ricardo Sánchez‐Prieto(Consejo Superior de Investigaciones Científicas)
Cited by 40
Related Papers
Full Activation of PKB/Akt in Response to Insulin or Ionizing Radiation Is Mediated through ATM
|Journal of Biological Chemistry|2004|272
Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance
|Oncotarget|2015|49
ERK2, but Not ERK1, Mediates Acquired and “De novo” Resistance to Imatinib Mesylate: Implication for CML Therapy
|PLoS ONE|2009|47
ERK5/BMK1 Is a Novel Target of the Tumor Suppressor VHL: Implication in Clear Cell Renal Carcinoma
|Neoplasia|2013|40
c‐Abl activates p38 MAPK independently of its tyrosine kinase activity: Implications in cisplatin‐based therapy
|International Journal of Cancer|2007|37